Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma

European Journal of Cancer

Volumn 38, Issue 17, 2002, Pages 2252-2257

  O'Hanlon, D M ^a   Fitzsimons, H ^a   Lynch, J ^a   Tormey, S ^a   Malone, C ^a   Given, H F ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Adhesion molecules; Breast carcinoma; E selectin; ICAM 1; Prognosis; VCAM 1

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CANCER STAGING; CANCER SURVIVAL; CELL INTERACTION; CONTROLLED STUDY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM; TUMOR CELL; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

BREAST NEOPLASMS; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0036849204     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00218-6     Document Type: Article

References (37)

1. Menger M.D., Vollmar B. Adhesion molecules as determinants of disease. from molecular biology to surgical research Br J Surg. 83:1996;588-601.
2. Gutman M., Fidler I.J. Biology of human colon cancer metastasis. World J Surg. 19:1995;226-234.
3. Zetter B.R. Adhesion molecules in tumor metastasis. Semin Cancer Biol. 4:1993;219-229.
4. Frenette P.S., Wagner D.D. Adhesion molecules - part 1. N Engl J Med. 334:1996;1526-1529.
5. Frenette P.S., Wagner D.D. Adhesion molecules - part II. blood vessels and blood cells N Engl J Med. 335:1996;43-45.
6. Meyer T., Hart I.R. Mechanisms of tumour metastasis. Eur J Cancer. 34:1998;214-221.
7. Gearing A.J., Hemingway I., Pigott R., Hughes J., Rees A.J., Cashman S.J. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1. pathological significance Ann N Y Acad Sci. 667:1992;324-331.
8. Gearing A.J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 14:1993;506-512.
9. Banks R.E., Gearing A.J., Hemingway I.K., Norfolk D.R., Perren T.J., Selby P.J. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 68:1993;122-124.
10. Hakomori S. Novel endothelial cell activation factors released from platelets which induce E-selectin expression and tumour cell adhesion to endothelial cells. a preliminary note Biochem Biophys Res Comm. 203:1994;1605-1613.
11. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 19:1991;403-410.
12. Steinbach F., Tanabe K., Alexander J.et al. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol. 155:1996;743-748.
13. Daneker G.W., Lund S.A., Caughman S.W., Staley C.A., Wood W.C. Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression. Clin Exp Metastasis. 14:1996;230-238.
14. Narita T., Kawakami-Kimura N., Matsuura N., Hosono J., Kannagi R. Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res. 15:1995;2523-2527.
15. Mitsuoka C., Kannagi R. Clinical significance of circulating soluble E-selectin (ELAM-1) in patients with cancers. Jap J Clin Med. 53:1995;1770-1775.
16. Zhang G.J., Adachi I. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma. correlations with clinicopathological features and prognosis Int J Oncol. 14:1999;71-77.
17. Muraki J., Kobayashi M., Sugaya Y.et al. Role of serum E-selectin (ELAM-1) and inflammatory parameters in patients with renal cell carcinoma. Jap J Urol. 87:1996;831-841.
18. Banner B.F., Savas L., Woda B.A. Expression of adhesion molecules in the host response to colon carcinoma. Ultrastructural Path. 19:1995;113-118.
19. Staal-van den Brekel A.J., Thunnissen F.B., Buurman W.A., Wouters E.F. Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non small-cell lung carcinoma. Virchows Archiv. 428:1996;21-27.
20. Santarosa M., Favaro D., Quaia M.et al. Expression and release of intercellular adhesion molecule-1 in renal cancer patients. Int J Cancer. 62:1995;271-275.
21. Becker J.C., Dummer R., Hartmann A.A., Burg G., Schmidt R.E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 147:1991;4398-4401.
22. Rivoltini L., Cattoretti G., Arienti F.et al. The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype. Int J Cancer. 47:1991;746-754.
23. Simmons D.L. The role of ICAM expression in immunity and disease. Cancer Surveys. 24:1995;141-155.
24. Tsujisaki M., Imai K., Hirata H.et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol. 85:1991;3-8.
25. Hamazaki K., Gochi A., Shimamura H.et al. Serum levels of circulating intercellular adhesion molecule in hepatocellular carcinoma. Hepato-Gastroenterology. 43:1996;229-234.
26. Pui C.H., Luo X. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood. 82:1993;895-898.
27. Hobarth K., Hallas A., Steiner G., Gomahr A., Aulitzky W., Marberger M. Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma. Urol Res. 24:1996;101-106.
28. Bao L., Pigott R., Matsumura, Baban D., Tarin D. Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation. 52:1993;239-246.
29. Rice G.E., Bevilacqua M.P. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science. 246:1989;1303-1306.
30. Byrne G.J., Ghelial A., Iddon J.et al. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst. 92:2000;1329-1336.
31. Giavazzi R., Nicoletti M.I., Chirivi R.G.et al. Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts. Eur J Cancer. 30:1994;1865-1870.
32. Harning R., Mainolfi E., Bystryn J.C., Henn M., Merluzzi V.J., Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 51:1991;5003-5005.
33. Becker J.C., Dummer R., Hartmann A.A., Burg G., Schmidt R.E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 147:1991;4398-4401.
34. Griffioen A.W., Damen C.A., Martinotti S., Blijham G.H., Groenewegen G. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies. the role of angiogenic factors Cancer Res. 56:1996;1111-1117.
35. Koyama S. Immnosuppressive effects of shedding intracellular adhesion molecule-1 antigen on cell mediated cytotoxicity against tumour cells. Jap J Cancer Res. 85:1994;131-134.
36. Koch A.E., Halloran M.M., Haskell C.J., Shah M.R., Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 376:1995;517-519.
37. Jain R.K., Koenig G.C., Dellian M., Fukumura D., Munn L.L., Melder R.J. Leukocyte-endothelial adhesion and angiogenesis in tumours. Cancer Metastases Rev. 15:1996;195-294.